Bionano Genomics Inc expected to post a loss of $3.02 a share - Earnings Preview

Bionano Genomics

12/05/2025 22:00

Bionano Genomics Inc BNGO.OQ BNGO.O is expected to show a fall in quarterly revenue when it reports  results on May 14 for the period ending March 31 2025

The San Diego California-based  company is expected to report a 28.9% decrease in revenue to $6.233 million from $8.77 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on March 31 2025, for the period ended March 31, was for revenue between $6.20 million and $6.30 million.

‚ÄãLSEG's mean analyst estimate for Bionano Genomics Inc is for a loss of $3.02 per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had risen by about 25.0% in the last three months. ‚Äã

Wall Street's median 12-month price target for Bionano Genomics Inc is $7.00‚Äã, above‚Äã its last closing price of $3.84. ‚Äã‚Äã‚Äã

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äã

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-6.00
-15.83
Missed
-163.8
Sep. 30 2024
-11.92
-12.60
-24.00
Missed
-90.5
Jun. 30 2024
-24.74
-25.00
-13.20
Beat
47.2‚Äã
Mar. 31 2024
-38.68
-38.70
-30.60
Beat
20.9
‚Äã‚ÄãDec. 31 2023
-52.16
-52.35
-24.60
Beat
53
Sep. 30 2023
-55.33
-58.20
-60.00
Missed
-3.1‚Äã
Jun. 30 2023
-60.00
-62.00
-74.40
Missed
-20
Mar. 31 2023
-66.00
-66.00
-72.00
Missed
-9.1

This summary was machine generated May 12 at 21:00 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)